Short Interest in StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Decreases By 76.9%

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) was the recipient of a significant drop in short interest in September. As of September 30th, there was short interest totalling 2,400 shares, a drop of 76.9% from the September 15th total of 10,400 shares. Based on an average trading volume of 12,200 shares, the days-to-cover ratio is currently 0.2 days.

StageZero Life Sciences Stock Performance

Shares of SZLSF traded up $0.03 during trading hours on Friday, hitting $0.07. 1,100 shares of the company were exchanged, compared to its average volume of 3,599. StageZero Life Sciences has a 52 week low of $0.00 and a 52 week high of $1.00. The firm’s 50 day moving average is $0.06 and its 200-day moving average is $0.03.

About StageZero Life Sciences

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood.